可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Schomig A, Neumann FJ, Knotrati A, et al. A randomized comparison of antiplatelet and antlicoagulant therapy after placement of coronary stents [J] . N Engl Med, 1996, 334:1084-1089.
[2] Reffelmann T, Vom Dahl J, Hendriks F, et al. Reduction of inhospital complications after selective percutaneous transluminal coronary angioplasty using a combined pretreatment with ticlopidine and aspirin [J] . Z Kardiol, 1998, 87:872-880.
[3] 郑鹏翔, 华尔铨, 何祚佑, 等. 阿司匹林、噻氯匹啶、肝素预防冠状动脉支架亚急性血栓形成的效果 [J] . 中国介入心脏病学杂志, 1999, 7:124-125.
[4] Leon MB, Baim DS, Popma JJ, et al. A clinical trail comparing three antithrombotic drug regimens after coronary-artery stenting [J] . N Engl J Med, 1998,3:1665-1671.
[5] Carrozza JP, Baim DS, Charles A. Thrombotic and hemorrhagic complications of stenting coronary arteries:incidence, management and prevention [J]. Thromb Thrombolysis, 1995, 1:289-297.
[6] 高润霖, 陈纪林, 杨跃进, 等. 冠状动脉内支架置入术1000例-单中心经验分析 [J] . 中国循环杂志, 1999, 14(suppl):1-3.
[7] Grubegr L, Dangas G, Leon MB. Coronary artery stents:appropriate use of adjunctive pharmacotherapy to preventstent thrombosis [J] . Drugs Aging, 1999, 15:314-318.
[8] Dangas G, Colombo A. Platelet glycoprotein Ⅱ b/Ⅲ a antagonists in percutaneous coronary revascularization [J] . Am Heart J, 1999, 138(1Pt2):S16-23.
[9] Zidar JP. Low-molecular-weight heparins in coronary stenting(the ENTICES Trail). Enoxaparin and Ticlopidine after elective stenting[J].Am J Cardiol, 1998,19:1130-1131.